Tema Heart & Health ETF (NASDAQ:HRTS – Get Free Report)’s stock price dropped 3.3% during trading on Thursday. The company traded as low as $38.47 and last traded at $38.5110. Approximately 6,008 shares traded hands during mid-day trading, an increase of 18% from the average daily volume of 5,088 shares. The stock had previously closed at $39.84.
Tema Heart & Health ETF Trading Up 0.2%
The firm has a market capitalization of $57.03 million, a PE ratio of 29.47 and a beta of 0.60. The business’s 50 day simple moving average is $36.98 and its two-hundred day simple moving average is $35.64.
Institutional Trading of Tema Heart & Health ETF
Several large investors have recently modified their holdings of the company. Royal Bank of Canada lifted its holdings in Tema Heart & Health ETF by 8.8% in the first quarter. Royal Bank of Canada now owns 21,083 shares of the company’s stock valued at $710,000 after acquiring an additional 1,703 shares during the period. XML Financial LLC bought a new stake in shares of Tema Heart & Health ETF during the 2nd quarter valued at about $223,000. Anson Capital Inc. purchased a new stake in shares of Tema Heart & Health ETF during the 2nd quarter valued at about $297,000. Members Advisory Group LLC purchased a new stake in shares of Tema Heart & Health ETF during the 2nd quarter valued at about $398,000. Finally, Rothschild Capital Partners LLC bought a new position in shares of Tema Heart & Health ETF in the 2nd quarter worth approximately $651,000.
Tema Heart & Health ETF Company Profile
The Tema Obesity & Cardiometabolic ETF (HRTS) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that concentrates on companies focused on the treatment of cardiovascular diseases and/or metabolic diseases from companies all around the world. Using both top-down and bottom-up stock selection, the fund identifies innovative companies deemed attractive. HRTS was launched on Nov 20, 2023 and is issued by Tema.
Featured Articles
- Five stocks we like better than Tema Heart & Health ETF
- Dutch Bros Gave Wall Street What It Wanted, So Why Did the Stock Crater?
- Astera Labs Just Crushed Earnings—So Why Are Analysts Cutting Price Targets?
- Sandisk Shares Are Oversold: Bargain or Value Trap?
- IonQ’s Record Revenue Includes a Big SkyWater Boost: Does That Change the Story?
Receive News & Ratings for Tema Heart & Health ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tema Heart & Health ETF and related companies with MarketBeat.com's FREE daily email newsletter.
